Apixaban clinical trials

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

This study looks back at French health records to understand how different blood-thinning medicines affect people with an irregular heartbeat (atrial fibrillation) who are at higher risk of stomach bleeding. It compares older medicines like warfarin with newer ones to see how safe and effective they are.

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

This study looks at whether blood-thinning medicines can help prevent blood clots after common varicose vein operations. It aims to see if giving these medicines after keyhole procedures for varicose veins is a good idea to keep you safe.

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

This study looks at whether a tablet called apixaban can stop blood clots in people with lung cancer who are having chemotherapy. Blood clots can be a serious problem, and apixaban is a 'blood thinner' designed to reduce this risk.

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

This study is testing a new medicine called Andexanet. It's for healthy people aged 18 to 55. We want to see how Andexanet works with common blood thinners like Rivaroxaban and Apixaban, and if it affects another blood thinner called Enoxaparin. This helps doctors understand how to use Andexanet safely.

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

This study is comparing two medicines, milvexian and apixaban, for people with an irregular heartbeat called atrial fibrillation. We want to see if milvexian is just as good as apixaban at stopping serious problems like strokes, which can happen with this condition.

Thromboprophylaxis in Lower Limb Immobilisation

This study looks at new ways to prevent blood clots after a leg injury treated with a cast or splint. It compares injections with tablets and also checks if medication helps those at lower risk of clots. The goal is to find safer and more effective options.

Anticoagulation in Patients With Venous Thromboembolism and Cancer

This study looks back at patient records to understand how different blood-thinning medicines work for people with cancer who have also had blood clots. It compares medicines like Apixaban, Rivaroxaban, and Dabigatran to see which are most effective and safe.

Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY)

This study looks at how weight loss after stomach surgery (Roux-en-Y gastric bypass) affects a common blood thinning medicine called apixaban. Researchers will measure how much medicine is in the blood before and after surgery, and also track weight and any bleeding or blood clot issues.

Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study. The PRADO study

Randomised, crossover bioequivalence clinical trial of apixaban 5 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions

A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)